JP2024536863A5 - - Google Patents
Info
- Publication number
- JP2024536863A5 JP2024536863A5 JP2024518817A JP2024518817A JP2024536863A5 JP 2024536863 A5 JP2024536863 A5 JP 2024536863A5 JP 2024518817 A JP2024518817 A JP 2024518817A JP 2024518817 A JP2024518817 A JP 2024518817A JP 2024536863 A5 JP2024536863 A5 JP 2024536863A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163248563P | 2021-09-27 | 2021-09-27 | |
| US63/248,563 | 2021-09-27 | ||
| US202163273407P | 2021-10-29 | 2021-10-29 | |
| US63/273,407 | 2021-10-29 | ||
| US202263371910P | 2022-08-19 | 2022-08-19 | |
| US63/371,910 | 2022-08-19 | ||
| PCT/US2022/077000 WO2023049886A1 (en) | 2021-09-27 | 2022-09-26 | Imidazopyridazine il-17 inhibitor compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024536863A JP2024536863A (ja) | 2024-10-08 |
| JP2024536863A5 true JP2024536863A5 (https=) | 2025-09-19 |
| JPWO2023049886A5 JPWO2023049886A5 (https=) | 2025-09-19 |
Family
ID=83693127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518817A Pending JP2024536863A (ja) | 2021-09-27 | 2022-09-26 | イミダゾピリダジンｉｌ－１７阻害剤化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12215111B2 (https=) |
| EP (1) | EP4408529A1 (https=) |
| JP (1) | JP2024536863A (https=) |
| KR (1) | KR20240082371A (https=) |
| AU (1) | AU2022348938A1 (https=) |
| CA (1) | CA3233625A1 (https=) |
| MX (1) | MX2024003770A (https=) |
| TW (1) | TW202329933A (https=) |
| UY (1) | UY39957A (https=) |
| WO (1) | WO2023049886A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240082371A (ko) | 2021-09-27 | 2024-06-10 | 얀센 파마슈티카 엔브이 | 이미다조피리다진 il-17 억제제 화합물 |
| TW202430165A (zh) | 2022-12-02 | 2024-08-01 | 丹麥商理奧藥品公司 | Il-17之小分子調節劑 |
| WO2024138286A1 (en) * | 2022-12-26 | 2024-07-04 | Usynova Pharmaceuticals, Ltd. | Il-17a modulators |
| WO2024163365A1 (en) * | 2023-01-30 | 2024-08-08 | Dice Alpha, Inc. | Benzimidazole and aza-benzimidazole based il-17a modulators and uses thereof |
| CN121311483A (zh) * | 2023-03-28 | 2026-01-09 | 詹森药业有限公司 | 含内酰胺的咪唑并哒嗪il-17抑制剂化合物 |
| WO2025202922A1 (en) * | 2024-03-27 | 2025-10-02 | Janssen Pharmaceutica Nv | Imidazopyridazine il-17 inhibitor compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI752400B (zh) * | 2019-01-07 | 2022-01-11 | 美商美國禮來大藥廠 | Il-17a抑制劑 |
| GB201909190D0 (en) * | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| KR20230019507A (ko) | 2020-04-30 | 2023-02-08 | 얀센 파마슈티카 엔.브이. | Il-17의 조절제로서의 이미다조피리다진 |
| WO2023025783A1 (en) | 2021-08-23 | 2023-03-02 | Leo Pharma A/S | Small molecule modulators of il-17 |
| KR20240082371A (ko) | 2021-09-27 | 2024-06-10 | 얀센 파마슈티카 엔브이 | 이미다조피리다진 il-17 억제제 화합물 |
| CN116143777A (zh) | 2021-11-04 | 2023-05-23 | 四川海思科制药有限公司 | 一种可抑制il-17a的杂环化合物及其用途 |
| TW202413363A (zh) | 2021-11-04 | 2024-04-01 | 大陸商西藏海思科製藥有限公司 | 一種可抑制il-17a之雜環化合物及其用途 |
-
2022
- 2022-09-26 KR KR1020247013538A patent/KR20240082371A/ko active Pending
- 2022-09-26 AU AU2022348938A patent/AU2022348938A1/en active Pending
- 2022-09-26 UY UY0001039957A patent/UY39957A/es not_active Application Discontinuation
- 2022-09-26 WO PCT/US2022/077000 patent/WO2023049886A1/en not_active Ceased
- 2022-09-26 CA CA3233625A patent/CA3233625A1/en active Pending
- 2022-09-26 JP JP2024518817A patent/JP2024536863A/ja active Pending
- 2022-09-26 TW TW111136298A patent/TW202329933A/zh unknown
- 2022-09-26 EP EP22790173.3A patent/EP4408529A1/en active Pending
- 2022-09-26 MX MX2024003770A patent/MX2024003770A/es unknown
- 2022-09-26 US US17/935,329 patent/US12215111B2/en active Active
-
2024
- 2024-12-09 US US18/973,307 patent/US20250206744A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024536863A5 (https=) | ||
| CL2025003984A1 (es) | Semaglutida en terapia médica. | |
| CL2025003539A1 (es) | Uso de información de asistencia de conmutación de célula para búsqueda de ssb durante conmutación de satélite | |
| BR102022025291A2 (https=) | ||
| CL2025003550A1 (es) | Sistema de archivos específico para la operación | |
| CL2025003402A1 (es) | Aplicador agrícola. | |
| BR102023014872A2 (https=) | ||
| BR102023012440A2 (https=) | ||
| BR102023010976A2 (https=) | ||
| BR102023008688A2 (https=) | ||
| BR102023007252A2 (https=) | ||
| BR102023005164A2 (https=) | ||
| BR102023001877A2 (https=) | ||
| BR102023000289A2 (https=) | ||
| BR102022026909A2 (https=) | ||
| BR202022009269U2 (https=) | ||
| BR202022005961U2 (https=) | ||
| BR202022000931U2 (https=) | ||
| CN307046000S (https=) | ||
| CN307047504S (https=) | ||
| CN307044340S (https=) | ||
| BY23966C1 (https=) | ||
| BY13161U (https=) | ||
| CN307044499S (https=) | ||
| BY23963C1 (https=) |